General Electric is taking a big step toward its goal of deleveraging its $121 billion debt load by selling part of its fast-growing life sciences division.
To read the entire story, you must be logged in.
Please log in now or register with us.
Intelligence for the Dealmaking Community since 1965
After clicking on a story, use the back arrow in your browser to return to your search results. Use phrases "in quotes" or the tools below to better filter your results.
